(Reuters) - An advisory panel to the U.S. Food and Drug Administration on Thursday unanimously voted in favor of approving the first cannabis-derived medicine in the country, a childhood epilepsy treatment developed by GW Pharma. The drug, Epidiolex, is derived from cannabidiol (CBD), one of the ...
read more here
Delivered by @can_nab_is
No comments:
Post a Comment